These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 11606415)

  • 1. Correspondence re: Y. Yamada et al., frequent beta-catenin gene mutations and accumulations of the protein in the putative preneoplastic lesions lacking macroscopic aberrant crypt foci appearance, in rat colon carcinogenesis. Cancer Res., 60: 3323-3327, 2000; and sequential analysis of morphological and biological properties of beta-catenin-accumulated crypts, provable premalignant lesions independent of aberrant crypt foci in rat colon carcinogenesis. Cancer Res., 61: 1874-1878, 2001.
    Pretlow TP; Bird RP
    Cancer Res; 2001 Oct; 61(20):7699-701. PubMed ID: 11606415
    [No Abstract]   [Full Text] [Related]  

  • 2. Frequent beta-catenin gene mutations and accumulations of the protein in the putative preneoplastic lesions lacking macroscopic aberrant crypt foci appearance, in rat colon carcinogenesis.
    Yamada Y; Yoshimi N; Hirose Y; Kawabata K; Matsunaga K; Shimizu M; Hara A; Mori H
    Cancer Res; 2000 Jul; 60(13):3323-7. PubMed ID: 10910031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequential analysis of morphological and biological properties of beta-catenin-accumulated crypts, provable premalignant lesions independent of aberrant crypt foci in rat colon carcinogenesis.
    Yamada Y; Yoshimi N; Hirose Y; Matsunaga K; Katayama M; Sakata K; Shimizu M; Kuno T; Mori H
    Cancer Res; 2001 Mar; 61(5):1874-8. PubMed ID: 11280741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered expression of beta-catenin, inducible nitric oxide synthase and cyclooxygenase-2 in azoxymethane-induced rat colon carcinogenesis.
    Takahashi M; Mutoh M; Kawamori T; Sugimura T; Wakabayashi K
    Carcinogenesis; 2000 Jul; 21(7):1319-27. PubMed ID: 10874009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Qualitative and quantitative relationship between dysplastic aberrant crypt foci and tumorigenesis in the Min/+ mouse colon.
    Paulsen JE; Steffensen IL; Løberg EM; Husøy T; Namork E; Alexander J
    Cancer Res; 2001 Jul; 61(13):5010-5. PubMed ID: 11431334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta-catenin expression is altered in human colonic aberrant crypt foci.
    Hao XP; Pretlow TG; Rao JS; Pretlow TP
    Cancer Res; 2001 Nov; 61(22):8085-8. PubMed ID: 11719432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of dysplastic aberrant crypt foci in the rat colon induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine.
    Ochiai M; Ushigome M; Fujiwara K; Ubagai T; Kawamori T; Sugimura T; Nagao M; Nakagama H
    Am J Pathol; 2003 Oct; 163(4):1607-14. PubMed ID: 14507667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant crypt foci and beta-catenin accumulated crypts; significance and roles for colorectal carcinogenesis.
    Mori H; Yamada Y; Kuno T; Hirose Y
    Mutat Res; 2004 May; 566(3):191-208. PubMed ID: 15082237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequent mutation of Apc gene in rat colon tumors and mucin-depleted foci, preneoplastic lesions in experimental colon carcinogenesis.
    Femia AP; Dolara P; Giannini A; Salvadori M; Biggeri A; Caderni G
    Cancer Res; 2007 Jan; 67(2):445-9. PubMed ID: 17234750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased beta-catenin expression and nuclear translocation accompany cellular hyperproliferation in vivo.
    Sellin JH; Umar S; Xiao J; Morris AP
    Cancer Res; 2001 Apr; 61(7):2899-906. PubMed ID: 11306465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the malignant potential of aberrant crypt foci by immunohistochemical staining for beta-catenin in inflammation-induced rat colon carcinogenesis.
    Furihata T; Kawamata H; Kubota K; Fujimori T
    Int J Mol Med; 2002 Apr; 9(4):353-8. PubMed ID: 11891526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pre-cancerous lesions for colorectal cancers in rodents: a new concept.
    Yamada Y; Mori H
    Carcinogenesis; 2003 Jun; 24(6):1015-9. PubMed ID: 12807742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution of preneoplastic lesions and tumors, and beta-catenin gene mutations in colon carcinomas induced by 1,2-dimethylhydrazine plus dextran sulfate sodium.
    Kinjo T; Suzui M; Morioka T; Nabandith V; Inamine M; Kaneshiro T; Arakaki J; Nishimaki T; Yoshimi N
    J Exp Clin Cancer Res; 2006 Mar; 25(1):89-95. PubMed ID: 16761624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The modifying effect of Peucedanum japonicum, a herb in the Ryukyu Islands, on azoxymethane-induced colon preneoplastic lesions in male F344 rats.
    Morioka T; Suzui M; Nabandith V; Inamine M; Aniya Y; Nakayama T; Ichiba T; Mori H; Yoshimi N
    Cancer Lett; 2004 Mar; 205(2):133-41. PubMed ID: 15036645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucin-depleted foci have beta-catenin gene mutations, altered expression of its protein, and are dose- and time-dependent in the colon of 1,2-dimethylhydrazine-treated rats.
    Femia AP; Bendinelli B; Giannini A; Salvadori M; Pinzani P; Dolara P; Caderni G
    Int J Cancer; 2005 Aug; 116(1):9-15. PubMed ID: 15751047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemoprevention of large bowel carcinogenesis; the role of control of cell proliferation and significance of beta-catenin-accumulated crypts as a new biomarker.
    Mori H; Yamada Y; Hirose Y; Kuno T; Katayama M; Sakata K; Yoshida K; Sugie S; Hara A; Yoshimi N
    Eur J Cancer Prev; 2002 Aug; 11 Suppl 2():S71-5. PubMed ID: 12570338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance and role of early-lesions in experimental colorectal carcinogenesis.
    Mori H; Hata K; Yamada Y; Kuno T; Hara A
    Chem Biol Interact; 2005 Jun; 155(1-2):1-9. PubMed ID: 15904905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic signatures of high- and low-risk aberrant crypt foci in a mouse model of sporadic colon cancer.
    Nambiar PR; Nakanishi M; Gupta R; Cheung E; Firouzi A; Ma XJ; Flynn C; Dong M; Guda K; Levine J; Raja R; Achenie L; Rosenberg DW
    Cancer Res; 2004 Sep; 64(18):6394-401. PubMed ID: 15374946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of occurrence and advancement of beta-catenin-accumulated crypts, possible premalignant lesions of colon cancer, by selective cyclooxygenase-2 inhibitor, celecoxib.
    Yamada Y; Yoshimi N; Hirose Y; Hara A; Shimizu M; Kuno T; Katayama M; Qiao Z; Mori H
    Jpn J Cancer Res; 2001 Jun; 92(6):617-23. PubMed ID: 11429049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-catenin antisense treatment decreases beta-catenin expression and tumor growth rate in colon carcinoma xenografts.
    Green DW; Roh H; Pippin JA; Drebin JA
    J Surg Res; 2001 Nov; 101(1):16-20. PubMed ID: 11676549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.